{"title_page": "Inflammatory cytokine", "text_new": "An  '''inflammatory cytokine''' or '''proinflammatory cytokine''' is a type of signaling molecule (a [[cytokine]]) that is secreted from immune cells like [[helper T cell]]s ('''T<sub>h</sub>''') and [[macrophage]]s, and certain other cell types that promote [[inflammation]]. They include [[interleukin-1]] (IL-1), [[interleukin 12|IL-12]], and [[interleukin 18|IL-18]], [[tumor necrosis factor|tumor necrosis factor alpha]] (TNF-\u03b1), [[interferon gamma]] (IFN\u03b3), and [[granulocyte-macrophage colony stimulating factor|granulocyte-macrophage colony stimulating factor (GM-CSF)]] and play an important role in mediating the [[innate immune response]]. Inflammatory cytokines are predominantly produced by and involved in the upregulation of inflammatory reactions.\n\nExcessive chronic production of inflammatory cytokines contribute to [[inflammatory disease]]s, that have been linked to different diseases, such as [[atherosclerosis]] and [[cancer]]. Dysregulation has also been linked to [[Mood disorder|depression]] and other neurological diseases. A balance between proinflammatory and anti-inflammatory cytokines is necessary to maintain health. [[Aging]] and [[exercise]] also play a role in the amount of inflammation from the release of proinflammatory cytokines.\n\nTherapies to treat inflammatory diseases include [[monoclonal antibody therapy|monoclonal antibodies]] that either neutralize inflammatory cytokines or their [[cytokine receptor|receptors]].\n\n==Definition==\nAn inflammatory cytokine is a type of [[cytokine]] (a signaling molecule) that is secreted from immune cells and certain other cell types that promotes [[inflammation]]. Inflammatory cytokines are predominantly produced by [[T helper cell]]s ('''T<sub>h</sub>''') and [[macrophage]]s and involved in the [[upregulation]] of inflammatory reactions.<ref name=\"Zhang 27\u201337\">{{cite journal | vauthors = Zhang JM, An J | title = Cytokines, inflammation, and pain | journal = International Anesthesiology Clinics | volume = 45 | issue = 2 | pages = 27\u201337 | pmid = 17426506 | doi = 10.1097/aia.0b013e318034194e | pmc=2785020 | year=2007}}</ref>  Therapies to treat inflammatory diseases include [[monoclonal antibody therapy|monoclonal antibodies]] that either neutralize inflammatory cytokines or their [[cytokine receptor|receptors]].<ref>{{cite journal | vauthors = Scarpioni R, Ricardi M, Albertazzi V | title = Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damage | journal = World Journal of Nephrology | volume = 5 | issue = 1 | pages = 66\u201375 | date = Jan 2016 | pmid = 26788465 | pmc = 4707170 | doi = 10.5527/wjn.v5.i1.66 }}</ref>\n\nInflammatory cytokines include [[interleukin-1]] (IL-1), [[interleukin 12|IL-12]], and [[interleukin 18|IL-18]], [[tumor necrosis factor|tumor necrosis factor alpha]] (TNF-\u03b1), [[interferon gamma]] (IFN\u03b3), and [[granulocyte-macrophage colony stimulating factor|granulocyte-macrophage colony stimulating factor (GM-CSF)]].<ref name=\"pmid11502077\">{{cite journal | vauthors = Cavaillon JM | title = Pro- versus anti-inflammatory cytokines: myth or reality | journal = Cellular and Molecular Biology (Noisy-le-Grand, France) | volume = 47 | issue = 4 | pages = 695\u2013702 | year = 2001 | pmid = 11502077 | doi = }}</ref>\n\n== Function ==\nInflammatory cytokines play a role in initiating the inflammatory response and to regulate the host defence against pathogens mediating the [[innate immune response]].{{citation needed|date=February 2017}} Some inflammatory cytokines have additional roles such as acting as [[Growth factor|growth factors]].<ref>{{cite book | last1 = Fitzgerald | first1 = Katherine A. | last2 = O'Neill | first2 = Luke A.J. | last3 = Gearing | first3 = Andy J.H. | last4 = Callard | first4 = Robin E. | name-list-format = vanc | title = The Cytokine Factsbook | date = 2001 | publisher = Academic Press | location = San Diego | isbn = 978-0-12-155142-1 | page = 2 | edition = 2nd }}</ref> \nPro-inflammatory cytokines such as IL-1\u03b2, IL-6, and TNF-\u03b1 also trigger pathological pain.<ref name=\"Zhang 27\u201337\"/> While IL-1\u03b2 is released by monocytes and macrophages, it is also present in nociceptive DRG neurons. IL-6 plays a role in neuronal reaction to an injury. TNF-\u03b1 is a well known proinflammatory cytokine present in neurons and the [[Neuroglia|glia]]. TNF-\u03b1 is often involved in different signaling pathways to regulate [[apoptosis]] in the cells.{{citation needed|date=February 2017}}\nExcessive chronic production of inflammatory cytokines contribute to [[inflammatory disease]]s.<ref name=\"wjgnet.com\">{{cite journal | vauthors = Scarpioni R, Ricardi M, Albertazzi V | title = Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damage | journal = World Journal of Nephrology | volume = 5 | issue = 1 | pages = 66\u201375 | date = Jan 2016 | pmid = 26788465 | pmc = 4707170 | doi = 10.5527/wjn.v5.i1.66 }}</ref> that have been linked to different diseases, such as [[atherosclerosis]] and [[cancer]]. Dysregulation of proinflammatory cytokines have also been linked to [[Mood disorder|depression]] and other neurological diseases. A balance between proinflammatory and anti-inflammatory cytokines is necessary to maintain health.  Aging and exercise also play a role in the amount of inflammation from the release of proinflammatory cytokines.<ref name=\"ReferenceA\">{{cite journal | vauthors = Sallam N, Laher I | title = Exercise Modulates Oxidative Stress and Inflammation in Aging and Cardiovascular Diseases | journal = Oxidative Medicine and Cellular Longevity | volume = 2016 | pages = 7239639 | date = 2015-12-28 | pmid = 26823952 | pmc = 4707375 | doi = 10.1155/2016/7239639 }}</ref>\n\n== Negative impacts ==\n\nDue to its proinflammatory action, a proinflammatory cytokine tends to make the disease itself or the symptoms correlated to a disease worse by causing [[fever]], [[inflammation]], tissue destruction, and in some cases, even [[Shock (circulatory)|shock]] and [[death]].<ref name=\"pmid10936147\">{{cite journal | vauthors = Dinarello CA | title = Proinflammatory cytokines | journal = Chest | volume = 118 | issue = 2 | pages = 503\u20138 | year = August 2000 | pmid = 10936147 | doi =10.1378/chest.118.2.503 }}</ref> Excessive amounts of proinflammatory cytokines have been shown to cause detrimental effects<ref name=\"wjgnet.com\"/>\n\n=== In the kidney ===\n\nA proinflammatory cytokine affects functions of transporters and [[Ion channel|ion channels]] from the [[nephron]]. As a result, there is a change in the activity of the [[Potassium|potassium ion]] (K+) channels that changes the transepithelial transport of solutes and water in the kidney.<ref>{{cite journal | vauthors = Nakamura K, Hayashi H, Kubokawa M | title = Proinflammatory Cytokines and Potassium Channels in the Kidney | language = en | journal = Mediators of Inflammation | volume = 2015 | pages = 362768 | date = 2015-10-05 | pmid = 26508816 | pmc = 4609835 | doi = 10.1155/2015/362768 }}</ref> The kidney [[proximal tubule]] cells produce proinflammatory cytokines in response to [[Lipopolysaccharide|lipopolysaccharide]]. Proinflammatory cytokines affect the renal K+ channels. IFN\u03b3 causes delayed suppression and acute stimulation of the 40 pS K+ channel. Also, [[Transforming growth factor beta family|transforming growth factor beta 1]] (TGF-\u03b21) activates the calcium-activated potassium channel ([[Calcium-activated potassium channel|KCa3.1]]) which could be involved the detrimental effects of renal [[fibrosis]].{{citation needed|date=February 2017}}\n\n=== Graft-vs-host disease ===\n\n[[Graft-versus-host disease]] (GvHD) targets [[Janus kinase 1|JAK 1]] and [[Janus kinase 2|2]], the human [[tyrosine kinase]] protein required for signaling in multiple cytokines. When these [[Kinase|kinases]] are activated, signal proteins of the signal transducer and activator of transcription [[STAT protein|(STAT)]] protein family - which include transcription factors for target genes that serve proinflammatory roles - are [[Phosphorylation|phosphorylated]].<ref>{{cite journal | vauthors = Teshima T, Reddy P, Zeiser R | title = Acute Graft-versus-Host Disease: Novel Biological Insights | journal = Biology of Blood and Marrow Transplantation | volume = 22 | issue = 1 | pages = 11\u20136 | date = Jan 2016 | pmid = 26453971 | doi = 10.1016/j.bbmt.2015.10.001 }}</ref> The severity of GvHD is highly variable and is influenced by the amount of native cells present in the environment along with other regulatory [[T cell|T cells]], [[T helper cell|T<sub>H</sub>1]], [[T helper cell|T<sub>H</sub>2]], or [[T helper cell|T<sub>H</sub>17]] phenotypes.<ref>{{cite journal | vauthors = Henden AS, Hill GR | title = Cytokines in Graft-versus-Host Disease | language = en | journal = Journal of Immunology | volume = 194 | issue = 10 | pages = 4604\u201312 | date = May 2015 | pmid = 25934923 | doi = 10.4049/jimmunol.1500117 }}</ref> Both CD4<sup>+</sup> and CD8 IL-17 producing T cells have been shown to cause aTH1, causing tissue inflammation and resulting in severe GVHD.<ref>{{cite journal | vauthors = van der Waart AB, van der Velden WJ, Blijlevens NM, Dolstra H | title = Targeting the IL17 pathway for the prevention of graft-versus-host disease | journal = Biology of Blood and Marrow Transplantation | volume = 20 | issue = 6 | pages = 752\u20139 | date = Jun 2014 | pmid = 24565991 | doi = 10.1016/j.bbmt.2014.02.007 }}</ref>\n\n=== In cystic fibrosis ===\n\nA proinflammatory cytokine causes hyperinflammation, the leading cause of lung tissue destruction in [[cystic fibrosis]].<ref>{{cite journal | vauthors = Bruscia EM, Bonfield TL | title = Innate and Adaptive Immunity in Cystic Fibrosis | journal = Clinics in Chest Medicine | volume = 37 | issue = 1 | pages = 17\u201329 | date = Mar 2016 | pmid = 26857765 | doi = 10.1016/j.ccm.2015.11.010 }}</ref> With such a strong inflammatory response and an elevated number of immune cells, lungs of cystic fibrosis patients cannot clear the bacteria and become more susceptible to infections. A high prevalence (40-70%) of patients with cystic fibrosis show signs of [[asthma]], possibly due to the primary deficiency in the [[cystic fibrosis transmembrane conductance regulator]] (CFTR).<ref>{{cite journal | vauthors = McCuaig S, Martin JG | title = How the airway smooth muscle in cystic fibrosis reacts in proinflammatory conditions: implications for airway hyper-responsiveness and asthma in cystic fibrosis | journal = The Lancet Respiratory Medicine | volume = 1 | issue = 2 | pages = 137\u201347 | date = Apr 2013 | pmid = 24429094 | doi = 10.1016/s2213-2600(12)70058-9 }}</ref> CFTR-deficient T-helper cells create an inflammatory environment that has high concentrations of TNF-\u03b1, IL-8, and IL-13, which contributes to increased contractility of airway smooth muscle.{{citation needed|date=February 2017}}\n\n=== In cardiovascular disease ===\n\n[[Atherosclerosis]] induces a dysfunctional endothelium, which recruits immune cells that form lesions. Proinflammatory mediators cause inflammation after [[Ligand|ligands]]  in the heart vasculature activate immune cells.<ref>{{cite journal | vauthors = Slocum C, Kramer C, Genco CA | title = Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis | language = en | journal = Journal of Internal Medicine | date = Jan 2016 | pmid = 26791914 | doi = 10.1111/joim.12476 | volume=280 | pages=114\u201328}}</ref> Recent studies have shown the ability of exercise to control oxidative stress and inflammation in cardiovascular disease.{{citation needed|date=February 2017}}\n\n=== In adipose tissue metabolism and obesity ===\nA proinflammatory cytokine may be present in [[Adipose tissue|adipose tissues]]. [[Adipocyte|Adipocytes]] generate TNF-\u03b1 and other [[Interleukin|interleukins]]. Cytokines derived from [[adipose tissue]] serve as remote regulators such as [[Hormone|hormones]]. Studies have shown that TNF-\u03b1 and IL-6 concentrations are elevated in [[obesity]].<ref>{{cite journal | vauthors = Coppack SW | title = Pro-inflammatory cytokines and adipose tissue | journal = The Proceedings of the Nutrition Society | volume = 60 | issue = 3 | pages = 349\u201356 | date = August 2001 | pmid = 11681809 | doi = 10.1079/PNS2001110 }}</ref> Obesity leaves an excess of nutrients for the body, thereby causing [[adipocyte]]s to release more proinflammatory cytokines. Classically activated macrophages in the visceral fat accumulate in the fat tissues and continuously release proinflammatory cytokines, causing chronic inflammation in obese individuals.{{citation needed|date=February 2017}}\n\n=== In osteoarthritis ===\nTNF-\u03b1, IL-1 and IL-6 have been found to play a pivotal role in [[cartilage]] matrix degradation and [[bone resorption]] in [[osteoarthritis]].<ref>{{cite journal |vauthors=Wang T, He C |title=Pro-inflammatory cytokines: The link between obesity and osteoarthritis |journal=Cytokine & Growth Factor Reviews |volume= |issue= |pages= |date=October 2018 |pmid=30340925 |doi=10.1016/j.cytogfr.2018.10.002 |type=Review}}</ref> Animal studies indicate that inflammatory cytokines may stimulate [[Chondrocyte|chondrocytes]] to release cartilage-degrading [[protease]] in osteoarthritis. This finding does not, however, necessarily translate to ''[[Homo sapiens]]'', as osteoarthritis in humans is considered to be more complex than any animal model.<ref>{{cite journal |vauthors=Goldring MB |title=The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models |journal=Connective Tissue Research |volume=40 |issue=1 |pages=1\u201311 |date=1999 |pmid=10770646 |doi= |type=Review}}</ref> \n\n== Clinical implications ==\nReducing the biological activity of proinflammatory cytokine can reduce the brunt of attack from diseases.<ref name=\"pmid10936147\" />\n\nBlocking IL-1 or TNF-\u03b1 has been highly successful in helping patients with rheumatoid arthritis, [[inflammatory bowel disease]],<ref name=\"pmid21530742\">{{cite journal | vauthors = Strober W, Fuss IJ | title = Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases | journal = Gastroenterology | volume = 140 | issue = 6 | pages = 1756\u201367 | date = May 2011 | pmid = 21530742 | doi = 10.1053/j.gastro.2011.02.016 | pmc=3773507}}</ref> or graft-vs-host disease (GvHD).<ref name=\"pmid10936147\" /> However, the strategy has not yet been successful in humans with sepsis.<ref name=\"pmid10936147\" /> Therapeutic effects of acupuncture may be related to the body's ability to suppress a range of proinflammatory cytokines such as [[tumor necrosis factor alpha|tumor necrosis factor alpha (TNF-\u03b1)]], [[IL1B|IL-1B]], [[interleukin 6|IL-6]], and [[interleukin 10|IL-10]].<ref>{{cite journal | vauthors = Wang XM, Walitt B, Saligan L, Tiwari AF, Cheung CW, Zhang ZJ | title = Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy | journal = Cytokine | volume = 72 | issue = 1 | pages = 86\u201396 | date = Mar 2015 | pmid = 25573802 | doi = 10.1016/j.cyto.2014.12.006 | quote = Even acupuncture may have therapeutic potential considering its effects on suppressing proinflammatory cytokines, TNF-\u03b1, IL-1\u03b2, IL-6, and IL-10 | pmc=4750385}}</ref> \n\n[[Estrogen]] has been shown to promote healing by decrease the production of various proinflammatory cytokines like IL-6, TNF-\u03b1, and macrophage migration inhibitory factor ([[Macrophage migration inhibitory factor|MIF]]). Increased MIF levels are often found at the site of chronic non-healing ulcers, with those levels dropping significantly with successful healing. A 2005 review of current experimental data shows that \"estrogen regulates healing almost exclusively via MIF down-regulation and identifies novel MIF-regulated gene targets and clusters associated with aberrant healing.\" By down-regulating MIF, estrogen can promote healing, as correlated by clinical studies on aging skin and skin wounds. Unfortunately, estrogen-therapy has known [[Carcinogen|carcinogenic]] effects<ref>{{Cite web|url=https://www.cancer.org/cancer/breast-cancer/treatment/hormone-therapy-for-breast-cancer.html|title=Hormone Therapy for Breast Cancer {{!}} American Cancer Society|website=www.cancer.org|language=en|access-date=2019-02-27}}</ref> as mentioned by the American Cancer Society (increased incidences of breast cancer in women who undergo [[Hormone replacement therapy|HRT]]). However, scientists could make important discoveries in the future by studying \"downstream effects on genes/factors that mediate the effects of estrogen on healing.\"<ref>{{Cite web|url=https://www.woundsresearch.com/article/4908|title=Hormonal Influences on Wound Healing: A Review of Current Experimental Data|website=Wounds Research|language=en|access-date=2019-02-27}}</ref>\n\nHistone deacetylate inhibitors ([[Histone deacetylase inhibitor|HDACi]]) can suppress proinflammatory cytokine production and reduce GvHD.{{citation needed|date=February 2017}}\n\n== References ==\n{{Reflist|33em}}\n\n{{Cytokines}}\n{{Cytokine receptor modulators}}\n\n[[Category:Cytokines]]\n", "text_old": "An  '''inflammatory cytokine''' or '''proinflammatory cytokine''' is a type of signaling molecule (a [[cytokine]]) that is secreted from immune cells like [[helper T cell]]s ('''T<sub>h</sub>''') and [[macrophage]]s, and certain other cell types that promote [[inflammation]]. They include [[interleukin-1]] (IL-1), [[interleukin 12|IL-12]], and [[interleukin 18|IL-18]], [[tumor necrosis factor|tumor necrosis factor alpha]] (TNF-\u03b1), [[interferon gamma]] (IFN\u03b3), and [[granulocyte-macrophage colony stimulating factor|granulocyte-macrophage colony stimulating factor (GM-CSF)]] and play an important role in mediating the [[innate immune response]]. Inflammatory cytokines are predominantly produced by and involved in the upregulation of inflammatory reactions.\n\nExcessive chronic production of inflammatory cytokines contribute to [[inflammatory disease]]s, that have been linked to different diseases, such as [[atherosclerosis]] and [[cancer]]. Dysregulation has also been linked to [[Mood disorder|depression]] and other neurological diseases. A balance between proinflammatory and anti-inflammatory cytokines is necessary to maintain health. [[Aging]] and [[exercise]] also play a role in the amount of inflammation from the release of proinflammatory cytokines.\n\nTherapies to treat inflammatory diseases include [[monoclonal antibody therapy|monoclonal antibodies]] that either neutralize inflammatory cytokines or their [[cytokine receptor|receptors]].\n\n==Definition==\nAn inflammatory cytokine is a type of [[cytokine]] (a signaling molecule) that is secreted from immune cells and certain other cell types that promotes [[inflammation]]. Inflammatory cytokines are predominantly produced by [[T helper cell]]s ('''T<sub>h</sub>''') and [[macrophage]]s and involved in the [[upregulation]] of inflammatory reactions.<ref name=\"Zhang 27\u201337\">{{cite journal | vauthors = Zhang JM, An J | title = Cytokines, inflammation, and pain | journal = International Anesthesiology Clinics | volume = 45 | issue = 2 | pages = 27\u201337 | pmid = 17426506 | doi = 10.1097/aia.0b013e318034194e | pmc=2785020 | year=2007}}</ref>  Therapies to treat inflammatory diseases include [[monoclonal antibody therapy|monoclonal antibodies]] that either neutralize inflammatory cytokines or their [[cytokine receptor|receptors]].<ref>{{cite journal | vauthors = Scarpioni R, Ricardi M, Albertazzi V | title = Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damage | journal = World Journal of Nephrology | volume = 5 | issue = 1 | pages = 66\u201375 | date = Jan 2016 | pmid = 26788465 | pmc = 4707170 | doi = 10.5527/wjn.v5.i1.66 }}</ref>\n\nInflammatory cytokines include [[interleukin-1]] (IL-1), [[interleukin 12|IL-12]], and [[interleukin 18|IL-18]], [[tumor necrosis factor|tumor necrosis factor alpha]] (TNF-\u03b1), [[interferon gamma]] (IFN\u03b3), and [[granulocyte-macrophage colony stimulating factor|granulocyte-macrophage colony stimulating factor (GM-CSF)]].<ref name=\"pmid11502077\">{{cite journal | vauthors = Cavaillon JM | title = Pro- versus anti-inflammatory cytokines: myth or reality | journal = Cellular and Molecular Biology (Noisy-le-Grand, France) | volume = 47 | issue = 4 | pages = 695\u2013702 | year = 2001 | pmid = 11502077 | doi = }}</ref>\n\n== Function ==\nInflammatory cytokines play a role in initiating the inflammatory response and to regulate the host defence against pathogens mediating the [[innate immune response]].{{citation needed|date=February 2017}} Some inflammatory cytokines have additional roles such as acting as [[Growth factor|growth factors]].<ref>{{cite book | last1 = Fitzgerald | first1 = Katherine A. | last2 = O'Neill | first2 = Luke A.J. | last3 = Gearing | first3 = Andy J.H. | last4 = Callard | first4 = Robin E. | name-list-format = vanc | title = The Cytokine Factsbook | date = 2001 | publisher = Academic Press | location = San Diego | isbn = 978-0-12-155142-1 | page = 2 | edition = 2nd }}</ref> \nPro-inflammatory cytokines such as IL-1\u03b2, IL-6, and TNF-\u03b1 also trigger pathological pain.<ref name=\"Zhang 27\u201337\"/> While IL-1\u03b2 is released by monocytes and macrophages, it is also present in nociceptive DRG neurons. IL-6 plays a role in neuronal reaction to an injury. TNF-\u03b1 is a well known proinflammatory cytokine present in neurons and the [[Neuroglia|glia]]. TNF-\u03b1 is often involved in different signaling pathways to regulate [[apoptosis]] in the cells.{{citation needed|date=February 2017}}\nExcessive chronic production of inflammatory cytokines contribute to [[inflammatory disease]]s.<ref name=\"wjgnet.com\">{{cite journal | vauthors = Scarpioni R, Ricardi M, Albertazzi V | title = Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damage | journal = World Journal of Nephrology | volume = 5 | issue = 1 | pages = 66\u201375 | date = Jan 2016 | pmid = 26788465 | pmc = 4707170 | doi = 10.5527/wjn.v5.i1.66 }}</ref> that have been linked to different diseases, such as [[atherosclerosis]] and [[cancer]]. Dysregulation of proinflammatory cytokines have also been linked to [[Mood disorder|depression]] and other neurological diseases. A balance between proinflammatory and anti-inflammatory cytokines is necessary to maintain health.  Aging and exercise also play a role in the amount of inflammation from the release of proinflammatory cytokines.<ref name=\"ReferenceA\">{{cite journal | vauthors = Sallam N, Laher I | title = Exercise Modulates Oxidative Stress and Inflammation in Aging and Cardiovascular Diseases | journal = Oxidative Medicine and Cellular Longevity | volume = 2016 | pages = 7239639 | date = 2015-12-28 | pmid = 26823952 | pmc = 4707375 | doi = 10.1155/2016/7239639 }}</ref>\n\n== Negative impacts ==\n\nDue to its proinflammatory action, a proinflammatory cytokine tends to make the disease itself or the symptoms correlated to a disease worse by causing [[fever]], [[inflammation]], tissue destruction, and in some cases, even [[Shock (circulatory)|shock]] and [[death]].<ref name=\"pmid10936147\">{{cite journal | vauthors = Dinarello CA | title = Proinflammatory cytokines | journal = Chest | volume = 118 | issue = 2 | pages = 503\u20138 | year = August 2000 | pmid = 10936147 | doi =10.1378/chest.118.2.503 }}</ref> Excessive amounts of proinflammatory cytokines have been shown to cause detrimental effects<ref name=\"wjgnet.com\"/>\n\n=== In the kidney ===\n\nA proinflammatory cytokine affects functions of transporters and [[Ion channel|ion channels]] from the [[nephron]]. As a result, there is a change in the activity of the [[Potassium|potassium ion]] (K+) channels that changes the transepithelial transport of solutes and water in the kidney.<ref>{{cite journal | vauthors = Nakamura K, Hayashi H, Kubokawa M | title = Proinflammatory Cytokines and Potassium Channels in the Kidney | language = en | journal = Mediators of Inflammation | volume = 2015 | pages = 362768 | date = 2015-10-05 | pmid = 26508816 | pmc = 4609835 | doi = 10.1155/2015/362768 }}</ref> The kidney [[proximal tubule]] cells produce proinflammatory cytokines in response to [[Lipopolysaccharide|lipopolysaccaride]]. Proinflammatory cytokines affect the renal K+ channels. IFN\u03b3 causes delayed suppression and acute stimulation of the 40 pS K+ channel. Also, [[Transforming growth factor beta family|transforming growth factor beta 1]] (TGF-\u03b21) activates the calcium-activated potassium channel ([[Calcium-activated potassium channel|KCa3.1]]) which could be involved the detrimental effects of renal [[fibrosis]].{{citation needed|date=February 2017}}\n\n=== Graft-vs-host disease ===\n\n[[Graft-versus-host disease]] (GvHD) targets [[Janus kinase 1|JAK 1]] and [[Janus kinase 2|2]], the human [[tyrosine kinase]] protein required for signaling in multiple cytokines. When these [[Kinase|kinases]] are activated, signal proteins of the signal transducer and activator of transcription [[STAT protein|(STAT)]] protein family - which include transcription factors for target genes that serve proinflammatory roles - are [[Phosphorylation|phosphorylated]].<ref>{{cite journal | vauthors = Teshima T, Reddy P, Zeiser R | title = Acute Graft-versus-Host Disease: Novel Biological Insights | journal = Biology of Blood and Marrow Transplantation | volume = 22 | issue = 1 | pages = 11\u20136 | date = Jan 2016 | pmid = 26453971 | doi = 10.1016/j.bbmt.2015.10.001 }}</ref> The severity of GvHD is highly variable and is influenced by the amount of native cells present in the environment along with other regulatory [[T cell|T cells]], [[T helper cell|T<sub>H</sub>1]], [[T helper cell|T<sub>H</sub>2]], or [[T helper cell|T<sub>H</sub>17]] phenotypes.<ref>{{cite journal | vauthors = Henden AS, Hill GR | title = Cytokines in Graft-versus-Host Disease | language = en | journal = Journal of Immunology | volume = 194 | issue = 10 | pages = 4604\u201312 | date = May 2015 | pmid = 25934923 | doi = 10.4049/jimmunol.1500117 }}</ref> Both CD4<sup>+</sup> and CD8 IL-17 producing T cells have been shown to cause aTH1, causing tissue inflammation and resulting in severe GVHD.<ref>{{cite journal | vauthors = van der Waart AB, van der Velden WJ, Blijlevens NM, Dolstra H | title = Targeting the IL17 pathway for the prevention of graft-versus-host disease | journal = Biology of Blood and Marrow Transplantation | volume = 20 | issue = 6 | pages = 752\u20139 | date = Jun 2014 | pmid = 24565991 | doi = 10.1016/j.bbmt.2014.02.007 }}</ref>\n\n=== In cystic fibrosis ===\n\nA proinflammatory cytokine causes hyperinflammation, the leading cause of lung tissue destruction in [[cystic fibrosis]].<ref>{{cite journal | vauthors = Bruscia EM, Bonfield TL | title = Innate and Adaptive Immunity in Cystic Fibrosis | journal = Clinics in Chest Medicine | volume = 37 | issue = 1 | pages = 17\u201329 | date = Mar 2016 | pmid = 26857765 | doi = 10.1016/j.ccm.2015.11.010 }}</ref> With such a strong inflammatory response and an elevated number of immune cells, lungs of cystic fibrosis patients cannot clear the bacteria and become more susceptible to infections. A high prevalence (40-70%) of patients with cystic fibrosis show signs of [[asthma]], possibly due to the primary deficiency in the [[cystic fibrosis transmembrane conductance regulator]] (CFTR).<ref>{{cite journal | vauthors = McCuaig S, Martin JG | title = How the airway smooth muscle in cystic fibrosis reacts in proinflammatory conditions: implications for airway hyper-responsiveness and asthma in cystic fibrosis | journal = The Lancet Respiratory Medicine | volume = 1 | issue = 2 | pages = 137\u201347 | date = Apr 2013 | pmid = 24429094 | doi = 10.1016/s2213-2600(12)70058-9 }}</ref> CFTR-deficient T-helper cells create an inflammatory environment that has high concentrations of TNF-\u03b1, IL-8, and IL-13, which contributes to increased contractility of airway smooth muscle.{{citation needed|date=February 2017}}\n\n=== In cardiovascular disease ===\n\n[[Atherosclerosis]] induces a dysfunctional endothelium, which recruits immune cells that form lesions. Proinflammatory mediators cause inflammation after [[Ligand|ligands]]  in the heart vasculature activate immune cells.<ref>{{cite journal | vauthors = Slocum C, Kramer C, Genco CA | title = Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis | language = en | journal = Journal of Internal Medicine | date = Jan 2016 | pmid = 26791914 | doi = 10.1111/joim.12476 | volume=280 | pages=114\u201328}}</ref> Recent studies have shown the ability of exercise to control oxidative stress and inflammation in cardiovascular disease.{{citation needed|date=February 2017}}\n\n=== In adipose tissue metabolism and obesity ===\nA proinflammatory cytokine may be present in [[Adipose tissue|adipose tissues]]. [[Adipocyte|Adipocytes]] generate TNF-\u03b1 and other [[Interleukin|interleukins]]. Cytokines derived from [[adipose tissue]] serve as remote regulators such as [[Hormone|hormones]]. Studies have shown that TNF-\u03b1 and IL-6 concentrations are elevated in [[obesity]].<ref>{{cite journal | vauthors = Coppack SW | title = Pro-inflammatory cytokines and adipose tissue | journal = The Proceedings of the Nutrition Society | volume = 60 | issue = 3 | pages = 349\u201356 | date = August 2001 | pmid = 11681809 | doi = 10.1079/PNS2001110 }}</ref> Obesity leaves an excess of nutrients for the body, thereby causing [[adipocyte]]s to release more proinflammatory cytokines. Classically activated macrophages in the visceral fat accumulate in the fat tissues and continuously release proinflammatory cytokines, causing chronic inflammation in obese individuals.{{citation needed|date=February 2017}}\n\n=== In osteoarthritis ===\nTNF-\u03b1, IL-1 and IL-6 have been found to play a pivotal role in [[cartilage]] matrix degradation and [[bone resorption]] in [[osteoarthritis]].<ref>{{cite journal |vauthors=Wang T, He C |title=Pro-inflammatory cytokines: The link between obesity and osteoarthritis |journal=Cytokine & Growth Factor Reviews |volume= |issue= |pages= |date=October 2018 |pmid=30340925 |doi=10.1016/j.cytogfr.2018.10.002 |type=Review}}</ref> Animal studies indicate that inflammatory cytokines may stimulate [[Chondrocyte|chondrocytes]] to release cartilage-degrading [[protease]] in osteoarthritis. This finding does not, however, necessarily translate to ''[[Homo sapiens]]'', as osteoarthritis in humans is considered to be more complex than any animal model.<ref>{{cite journal |vauthors=Goldring MB |title=The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models |journal=Connective Tissue Research |volume=40 |issue=1 |pages=1\u201311 |date=1999 |pmid=10770646 |doi= |type=Review}}</ref> \n\n== Clinical implications ==\nReducing the biological activity of proinflammatory cytokine can reduce the brunt of attack from diseases.<ref name=\"pmid10936147\" />\n\nBlocking IL-1 or TNF-\u03b1 has been highly successful in helping patients with rheumatoid arthritis, [[inflammatory bowel disease]],<ref name=\"pmid21530742\">{{cite journal | vauthors = Strober W, Fuss IJ | title = Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases | journal = Gastroenterology | volume = 140 | issue = 6 | pages = 1756\u201367 | date = May 2011 | pmid = 21530742 | doi = 10.1053/j.gastro.2011.02.016 | pmc=3773507}}</ref> or graft-vs-host disease (GvHD).<ref name=\"pmid10936147\" /> However, the strategy has not yet been successful in humans with sepsis.<ref name=\"pmid10936147\" /> Therapeutic effects of acupuncture may be related to the body's ability to suppress a range of proinflammatory cytokines such as [[tumor necrosis factor alpha|tumor necrosis factor alpha (TNF-\u03b1)]], [[IL1B|IL-1B]], [[interleukin 6|IL-6]], and [[interleukin 10|IL-10]].<ref>{{cite journal | vauthors = Wang XM, Walitt B, Saligan L, Tiwari AF, Cheung CW, Zhang ZJ | title = Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy | journal = Cytokine | volume = 72 | issue = 1 | pages = 86\u201396 | date = Mar 2015 | pmid = 25573802 | doi = 10.1016/j.cyto.2014.12.006 | quote = Even acupuncture may have therapeutic potential considering its effects on suppressing proinflammatory cytokines, TNF-\u03b1, IL-1\u03b2, IL-6, and IL-10 | pmc=4750385}}</ref> \n\n[[Estrogen]] has been shown to promote healing by decrease the production of various proinflammatory cytokines like IL-6, TNF-\u03b1, and macrophage migration inhibitory factor ([[Macrophage migration inhibitory factor|MIF]]). Increased MIF levels are often found at the site of chronic non-healing ulcers, with those levels dropping significantly with successful healing. A 2005 review of current experimental data shows that \"estrogen regulates healing almost exclusively via MIF down-regulation and identifies novel MIF-regulated gene targets and clusters associated with aberrant healing.\" By down-regulating MIF, estrogen can promote healing, as correlated by clinical studies on aging skin and skin wounds. Unfortunately, estrogen-therapy has known [[Carcinogen|carcinogenic]] effects<ref>{{Cite web|url=https://www.cancer.org/cancer/breast-cancer/treatment/hormone-therapy-for-breast-cancer.html|title=Hormone Therapy for Breast Cancer {{!}} American Cancer Society|website=www.cancer.org|language=en|access-date=2019-02-27}}</ref> as mentioned by the American Cancer Society (increased incidences of breast cancer in women who undergo [[Hormone replacement therapy|HRT]]). However, scientists could make important discoveries in the future by studying \"downstream effects on genes/factors that mediate the effects of estrogen on healing.\"<ref>{{Cite web|url=https://www.woundsresearch.com/article/4908|title=Hormonal Influences on Wound Healing: A Review of Current Experimental Data|website=Wounds Research|language=en|access-date=2019-02-27}}</ref>\n\nHistone deacetylate inhibitors ([[Histone deacetylase inhibitor|HDACi]]) can suppress proinflammatory cytokine production and reduce GvHD.{{citation needed|date=February 2017}}\n\n== References ==\n{{Reflist|33em}}\n\n{{Cytokines}}\n{{Cytokine receptor modulators}}\n\n[[Category:Cytokines]]\n", "name_user": "NichoChem", "label": "safe", "comment": "saccharide mis-spelled", "url_page": "//en.wikipedia.org/wiki/Inflammatory_cytokine"}
